viernes, 22 de julio de 2016

Researchers at the Texas Center for Cancer Nanomedicine (TCCN) are developing and applying a diverse array of nanoplatforms for new therapeutics, methodologies for reliable monitoring of therapeutic efficacy, early detection approaches from biological fluids, and advances in imaging, and cancer-prevention protocols for ovarian and pancreatic cancers. One project is developing spherical silica nanoparticles coated with gold that produce heat upon exposure to near-infrared light, enabling specific thermal destruction of cancer cells. Here, nanoshells (red) are observed traveling through the blood vessels of a human glioma grown in a mouse